CS254544B1 - 2,3-bis/benzamido/phenazines - Google Patents
2,3-bis/benzamido/phenazines Download PDFInfo
- Publication number
- CS254544B1 CS254544B1 CS863359A CS335986A CS254544B1 CS 254544 B1 CS254544 B1 CS 254544B1 CS 863359 A CS863359 A CS 863359A CS 335986 A CS335986 A CS 335986A CS 254544 B1 CS254544 B1 CS 254544B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- bis
- mol
- phenazines
- benzamido
- recrystallized
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
kde R je atom vodíku a R atom chloru nebo nitroskupina nebo R^ je atom vodíku a RÍ nitroskupiná'. Tyto nové, dosud nepopsané látky vykazují anthelmintiokou účinnost proti modelovému helmintu Hymenolepiwherein R is hydrogen and R is chlorine or nitro or R 1 is hydrogen and R 1 nitrogroup. These new, not yet described substances show anthelmintic activity against model helmint Hymenolepi
Description
254544 2
Vynález se týká 2,3-bis(benzamido)fenazinů obecného vzorce I
12 2 1kde R je atom vodíku a R atom chloru nebo nitroskupina nebo R je atom vodíku a R nitro-skupina.
Tyto nové, dosud nepopsané látky vykazují použitelnou anthelmintickou účinnost, zejménaproti modelovému helmintu Hymenolepis nana.
Sloučeniny obecného vzorce I lze připravit reakcí 2,3-diaminofenazinu s chloridem kyse-liny 4-chlorbenzoové nebo 3-nitrobenzoové nebo 4-nitrobenzoové v prostředí pyridinu při tep-lotě 20 až 30 °C.
Hodnocení anthelmintické účinnosti proti modelovému helmintu Hymenolepis nana:
Testy byly provedeny na myších samcích kmene H s hmotností 10 až 13 g ve skupinách po6 kusech. Dvě ze tří kontrolních skupin byly invadované, neléčené, třetí invadovaná, léčenástandardním přípravkem - piperazinovou solí niclosamidu - vůči němuž byla účinnost látek po-rovnávána .
Invaze byla prováděna sondou perorálně vždy 500 zralými vajíčky Hymenolepis nana v objemu0,25 ml/myš. Sloučeniny obecného vzorce I byly aplikovány 13. a 14. den po invazi perorálněsondou v dávce 150 mg.kg 1 živé hmotnosti (ž. hm.). Standard byl aplikován rovněž 13. a 14.den po invazi v dávce 150 mg.kg 1 ž. hm., což přepočteno na niclosamid znamená dávku4,58.10-4 ž. hm.
Anthelmintické účinnost sloučenin obecného vzorce I vyjádřená v procentech metodou nepří-mé aktivity podle Stewarda je uvedena níže.
Substituent ve vzorci I dávka mol.kg 1 ž. hm. účinnost v % metodou nepříméaktivity příklad provedení R1 R2 H Cl 3,07.10-4 94,4 1 N02 H 2,86.10-4 67,2 2 H N°2 2,95.10-4 61,4 3
Způsob přípravy látek podle vynálezu je jednoduchý a poskytuje žádané produkty v uspoko-jivých výtěžcích. Bližší podrobnosti vyplývají z následujících příkladů provedení. Uvedenépříklady vynález pouze ilustrují, nikoliv omezují. Pří k.l a d 1 2,3-bis(4-chlorbenzamido)fenazin K suspenzi 10,51 g (0,05 mol) 2,3-diaminofenazinu ve 100 ml pyridinu bylo za míchání přiteplotě 20 až 30 °C přikapáno 17,53 g (0,1 mol) 4-chlorbenzoylchloridu a směs míchána 6 h při
254544 2
The invention relates to 2,3-bis (benzamido) phenazines of the formula I
Where R is hydrogen and R is chlorine or nitro or R is hydrogen and R is nitro.
These novel compounds, which have not yet been described, exhibit useful anthelmintic activity, in particular against the Hymenolepis nana model helminth.
Compounds of formula I may be prepared by reacting 2,3-diaminophenazine with 4-chlorobenzoic acid chloride or 3-nitrobenzoic acid or 4-nitrobenzoic acid in pyridine at 20-30 ° C.
Evaluation of anthelmintic activity against model Hymenolepis nana helminth:
Tests were performed on male H mice weighing 10-13 g in groups of 6 pieces. Two of the three control groups were invaded, untreated, third invaded, treated with the standard formulation - piperazine niclosamide salt - against which the efficacy of the compounds was compared.
Invasion was performed by probing orally with 500 mature Hymenolepis nana eggs at a volume of 0.25 ml / mouse. Compounds of formula I were administered on days 13 and 14 after peroral invasion at a dose of 150 mg / kg body weight (w / w). The standard was also applied on the 13th and 14th day after the invasion at a dose of 150 mg / kg. wt., calculated as niclosamide means a dose of 4.58.10-4.. wt.
The anthelmintic activity of the compounds of formula I as a percentage of the indirect activity according to the Steward is given below.
Substituent in Formula I is a dose of 1 kg. wt. efficiency in% by indirect activity example design example R1 R2 H Cl 3.07.10-4 94.4 1 NO 2 H 2.86.10-4 67.2 2 HN ° 2 2.95.10-4 61.4 3
The process for preparing the compounds of the invention is simple and provides the desired products in satisfactory yields. Further details are given in the following examples. The examples are merely illustrative, not limiting. Example 1 2,3-bis (4-chlorobenzamido) phenazine To a suspension of 10.51 g (0.05 mol) 2,3-diaminophenazine in 100 ml pyridine was added 17.53 g dropwise with stirring at 20 to 30 ° C. (0.1 mol) 4-chlorobenzoyl chloride and stirred for 6 h at rt
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS863359A CS254544B1 (en) | 1986-05-08 | 1986-05-08 | 2,3-bis/benzamido/phenazines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS863359A CS254544B1 (en) | 1986-05-08 | 1986-05-08 | 2,3-bis/benzamido/phenazines |
Publications (2)
Publication Number | Publication Date |
---|---|
CS335986A1 CS335986A1 (en) | 1987-05-14 |
CS254544B1 true CS254544B1 (en) | 1988-01-15 |
Family
ID=5373392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS863359A CS254544B1 (en) | 1986-05-08 | 1986-05-08 | 2,3-bis/benzamido/phenazines |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS254544B1 (en) |
-
1986
- 1986-05-08 CS CS863359A patent/CS254544B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CS335986A1 (en) | 1987-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0165422A1 (en) | Substituted bis-(4-aminophenyl)-sulphones, their preparation and their use as medicines | |
CS254544B1 (en) | 2,3-bis/benzamido/phenazines | |
DE1201337B (en) | Process for the preparation of benzene sulfonylureas | |
CH676599A5 (en) | ||
DE2056606C3 (en) | Alkyl hydrazine carbodithioate derivatives | |
DE1258412B (en) | Process for the preparation of 5,5-bis- (p-hydroxyphenyl) -imidazolinonen- (4) and their salts | |
CH516593A (en) | Alpha amino-benzyl penicillins - useful as oral antibiotics | |
DE1026301B (en) | Process for the preparation of antifungal 4-halosalicylic acid amides | |
EP0324988A1 (en) | 4-Chlor-3-sulfamoyl benzoic acid hydrazides, process for their preparation, medicines containing them and use of these compounds in the preparation of diuretic and salt reducing activity medicines | |
AT220626B (en) | Process for the preparation of new benzenesulfonylureas | |
US3464986A (en) | Thio-carbamyl-gamma-lactones | |
AT233584B (en) | Process for the production of new hydrindene sulfonylureas | |
AT222110B (en) | Process for the preparation of 4-chloro-3-sulfamylbenzamides | |
AT286495B (en) | Process for the preparation of new esters of α-amino-benzylpenicillin | |
AT219028B (en) | Process for the preparation of new trichloromethanesulfenic acid derivatives | |
CH364795A (en) | Process for the preparation of quaternary ammonium salts | |
DE3445011A1 (en) | Novel aniline derivative, process for its preparation, and its use | |
DE959551C (en) | Process for the preparation of 4-substituted 1-carbobenzoxypiperazines | |
DE4114543A1 (en) | NEW AMIDRAZONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A LIPOXYGENASE INHIBITOR | |
DE1962154A1 (en) | Basically subst coumarin derivs | |
DE2406817A1 (en) | PENICILLIN AND CEPHALOSPORINESTER, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
EP0097127A2 (en) | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | |
DE2617198A1 (en) | 6-N-PROPOXYBENZTHIAZOL-2-METHYLCARBAMATE, METHOD OF ITS MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING IT | |
DE1139507B (en) | Process for the preparation of N'-substituted N-thiophenesulfonyl ureas | |
DE1142866B (en) | Process for the preparation of dithiophosphoric acid ester diamides |